Furthermore, a recent study discovered that dual inhibition of BRAFV600E and MEK with dabrafenib and trametinib potently suppressed the expression of several genes of the homologous repair pathway in a subset of melanoma cell lines, including BRIP1, BRCA2, EME1 and RBBP8 [41]. This evidence concerns the gene MAP2K7 and melanoma.